NASDAQ$DHC

Diversified Heal · Q1 2022 earnings

Q1 2022 earnings · · Investor relations

Briefing

Announced first quarter 2022 results, reporting net income attributable to common shareholders of $1.01 per share.

Diversified Healthcare Trust reported strong sequential quarter NOI growth in its same property SHOP segment, driven by increases in rate. Leasing results in the Office Portfolio remained resilient. The company generated $653 million of cash through a new joint venture, bringing the total cash position to approximately $1.5 billion at quarter end.

  • Reported net income attributable to common shareholders of $240.4 million, or $1.01 per share.
  • Reported normalized funds from operations, or Normalized FFO, attributable to common shareholders of $(21.9) million, or $(0.09) per share.
  • Recorded a gain on sale of properties of $327.5 million, or $1.38 per share, from DHC's new joint venture.
  • As of March 31, 2022, DHC had approximately $1.5 billion of cash and cash equivalents and restricted cash.

Headline financials

Total Revenue

$311M

Previous: $363M-14.3%
EPS (adj)

-$0.09

Previous: $0.02-550.0%
Capital Expenditures

-$55.8M

Previous: -$44M-26.8%
Free Cash Flow

$185M

Previous: -$112M+265.6%
Net Income

$240M

Previous: -$67.5M+456.2%
Operating Income

-$276M

Previous: -$295M+6.4%
Gross Profit

$42M

Previous: $75.3M-44.3%
Cash & Equivalents

$732M

Previous: $843M-13.2%
Total Assets

$6.78B

Previous: $7.54B-10.2%

Revenue & EPS history

Diversified Heal · Revenue · Quarterly

$311M

Q1 2022-14.3%vs Q1 2021
Beat estimate in 8 of 16 quarters(50%)
ActualEstimate

Revenue by segment

Diversified Heal · $245M total across 1 segment · Q1 2022

  • SHOP
    $245M

Forward guidance

DHC anticipates continued growth and recovery, supported by liquidity and strategic investments. However, the company faces risks related to economic conditions, debt compliance, and the performance of its tenants and managers.

Tailwinds

  • Strong sequential quarter NOI growth in same property SHOP segment driven by rate increases.
  • Resilient leasing results in the Office Portfolio supporting overall business recovery.
  • Generated $653 million of cash from a new joint venture, increasing cash position to approximately $1.5 billion.
  • Amendment and extension of credit facility enhances capacity to fund investment activities.
  • Confident in DHC’s growth trajectory moving forward due to ample liquidity, improving operating performance, and solid leasing results.

Headwinds

  • SHOP business is subject to various risks, many of which are beyond its control, including the COVID-19 pandemic and other economic and market conditions, such as the current inflationary conditions.
  • DHC may not continue to realize positive leasing results, and even if it does, these results may not significantly increase the financial performance of DHC's portfolio.
  • This enhancement may not be sufficient, DHC may not succeed in executing its business plan and any such success it may have doing so may not realize the benefits it expects
  • If economic conditions worsen and the resulting impacts on DHC and its managers and tenants significantly worsen for a sustained period, or if they otherwise fail to profitably operate their businesses, DHC may be required to utilize all or a significant portion of its cash and cash equivalents to fund its business and operations.
  • DHC's ratio of consolidated income available for debt service to debt service was below the 1.5x incurrence requirement under its revolving credit facility and its public debt covenants as of March 31, 2022, and DHC cannot be certain how long this ratio will remain below 1.5x.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2022

Historical avgQ1 2022

+0.9%

Avg return

Earnings day

+3.9%

Avg return

5 days after

+7.8%

Avg return

30 days after

50%

34 / 68 earnings

Positive

+51.0%

Q4 2022

Best reaction

-18.4%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.1%+7.8%+8.9%
Q4 2025-2.3%+9.9%+11.7%
Q3 2025+5.5%+4.9%+12.9%
Q1 2025+30.7%+38.5%+50.5%
Q4 2024+8.6%+12.2%+0.8%
Q3 2024-18.4%-24.2%-25.9%
Q2 2024-2.7%-5.7%+4.2%
Q1 2024-11.8%-13.4%+13.7%
Q4 2023+8.4%+8.8%-18.6%
Q3 2023+7.2%+7.7%+28.0%
Q2 2023+12.0%+29.2%+30.1%
Q1 2023+0.6%+0.0%+163.6%
Q4 2022+51.0%+82.7%+37.8%
Q3 2022-13.2%-5.9%-27.2%
Q2 2022+1.2%+9.9%-16.3%
Q1 2022+6.9%+0.0%-1.8%
Q4 2021-4.5%-7.1%-2.6%
Q3 2021-10.3%-7.1%-29.7%
Q2 2021+1.8%+1.3%-3.1%
Q1 2021-7.1%-6.4%-13.9%
Q4 2020+0.9%+1.5%+6.7%
Q3 2020-6.3%+27.0%+49.5%
Q2 2020+6.9%+3.8%-5.5%
Q1 2020+8.7%-2.0%+104.7%
Q4 2019+6.7%-0.3%-52.9%
Q3 2019-8.7%-14.8%-16.0%
Q2 2019+6.7%+8.2%+3.8%
Q1 2019+2.3%+2.3%+1.5%
Q4 2018-8.2%-8.6%-9.0%
Q3 2018-2.7%-0.2%-15.9%
Q2 2018+0.9%-2.6%+3.6%
Q1 2018+2.0%+1.7%+9.5%
Q4 2017-4.3%-2.8%-1.0%
Q3 2017+1.1%+1.9%+0.4%
Q2 2017-1.8%-1.1%+2.9%
Q1 2017-1.1%-0.5%+3.2%
Q4 2016+1.5%+1.6%+0.7%
Q3 2016-1.8%-5.6%-8.1%
Q2 2016-2.4%-1.1%+2.7%
Q1 2016+2.4%
Q4 2015+0.4%
Q3 2015-2.4%
Q2 2015-1.2%
Q1 2015-1.0%
Q4 2014-0.4%
Q3 2014-1.5%
Q2 2014-1.5%
Q1 2014-0.7%
Q4 2013+4.3%
Q3 2013-1.2%
Q2 2013-4.7%
Q1 2013-0.6%
Q4 2012+0.9%
Q3 2012+1.5%
Q2 2012-0.8%
Q1 2012+0.1%
Q4 2011-1.3%
Q4 2010-1.3%
Q3 2011-2.9%
Q2 2011+0.6%
Q1 2010-2.5%
Q1 2011-0.1%
Q4 2008+4.0%
Q3 2010+1.7%
Q3 2009+1.7%
Q2 2010+1.3%
Q2 2009+1.3%
Q4 2009+1.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro